Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Stanford University
Information provided by (Responsible Party):
Accuray Incorporated
ClinicalTrials.gov Identifier:
NCT01318200
First received: March 16, 2011
Last updated: February 16, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: February 2016
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)